Older adults with history of head injuries show decreased brain function
By (0)
Head injuries may affect cognitive performance later in life, a new study has found. Photo by Toubibe/Pixabay
March 11 (UPI) Adults who suffer head injuries in their 50s or younger produce lower-than-expected scores on cognitive tests at age 70, a study published Thursday by the Annals of Clinical and Translational Neurology found.
Although head injuries do not appear to contribute to Alzheimer s disease-related brain damage, they may make people more vulnerable to dementia symptoms, the researchers said.
Advertisement
Seventy-year-olds who had experienced a serious head injury 15 or more years earlier on average scored 46 on 93-point cognitive tests for attention and quick thinking, lower than the 48 for those without a history of head injuries, the data showed.
Here s how head injuries may worsen cognitive decline decades later
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Bakan Pakdemirli: 2 milyar lira hibe saðladýk
star.com.tr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from star.com.tr Daily Mail and Mail on Sunday newspapers.
Share
A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia.
The clinical trial program (MoST–P), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.
UNSW Dean of Medicine & Health, Professor Vlado Perkovic said the grant could lead to better outcomes for pancreatic cancer patients and more personalised approaches to treatment.
“Our researchers constantly challenge existing knowledge on cancer and are at the forefront of advances in cancer research. The trial announced today is an exciting development in pancreatic cancer research and offers hope for the future for people affected by this terrible disease,” Prof. Perkovic said.